TAXUS PHARMACEUTICALS HOLDINGS, INC.: key financial figures for fiscal year 2017 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2017)
- $5.9K
- Net Income/Loss (FY2017)
- -$117.0K
- Total Assets (FY2017)
- $8.9K
- Total Equity (FY2017)
- -$53.7K
- Cash Flows from Operating Activities (FY2017)
- -$98.8K
Source: TAXUS PHARMACEUTICALS HOLDINGS, INC. 10-K filing (FY2017). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
